Esperion Therapeutics
ESPR
ESPR
205 hedge funds and large institutions have $478M invested in Esperion Therapeutics in 2026 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 65 increasing their positions, 60 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
8% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 60
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less capital invested
Capital invested by funds: $560M → $478M (-$81.6M)
Holders
205
Holding in Top 10
1
Calls
$11.5M
Puts
$2.57M
Top Buyers
| 1 | +$20M | |
| 2 | +$14.9M | |
| 3 | +$14.6M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$12.6M |
| 5 |
AC
Armistice Capital
New York
|
+$12.4M |
Top Sellers
| 1 | -$10.5M | |
| 2 | -$6.7M | |
| 3 | -$4.96M | |
| 4 |
RA
Royce & Associates
New York
|
-$3.09M |
| 5 |
Jane Street
New York
|
-$3.03M |
